Related Experiment Video

Updated: Jul 15, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Is significant relevant? Validity and patient benefit of randomized controlled clinical trials on age-related macular

Antonia M Joussen1, Walter Lehmacher, Ralf-Dieter Hilgers

  • 1Department of Ophthalmology, University of Düsseldorf, Düsseldorf, Germany.

Survey of Ophthalmology
|May 3, 2007
PubMed

Insights

New treatments for age-related macular degeneration (ARMD) show promise, but clinical trials may not reflect patient needs. This review examines trial validity and patient benefit in ARMD research.

Area of Science:

  • Ophthalmology
  • Clinical Trials
  • Medical Research

Background:

  • Numerous novel therapeutic interventions are emerging for age-related macular degeneration (ARMD).
  • Patient and clinician expectations regarding treatment efficacy may not always align with study outcomes.
  • Statistical significance in clinical trials does not always guarantee patient-relevant benefits.

Purpose of the Study:

  • To critically analyze the external validity of randomized controlled trials (RCTs) investigating ARMD treatments.
  • To evaluate clinical study endpoints in ARMD research concerning their relevance to patient benefit.

Main Methods:

  • Review of existing literature on ARMD clinical trials.
  • Analysis of methodologies used in randomized controlled trials.
  • Examination of outcome measures and endpoints reported in ARMD studies.

Main Results:

  • RCTs, the "gold standard" for intervention evaluation, may face challenges with external validity.
  • Patient selection in ARMD trials can lead to unrepresentative study groups, potentially limiting generalizability.
  • Endpoints chosen for ARMD trials may not always capture the patient's perspective on treatment success.

Conclusions:

  • There is a need to ensure that ARMD clinical trial designs and endpoints are relevant to patient needs and real-world outcomes.
  • Improving the external validity of ARMD RCTs is crucial for accurately assessing treatment benefits.
  • Further research should focus on patient-centered outcomes in ARMD clinical trials.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...